As on Thursday, Climb Bio Inc (NASDAQ: CLYM) got off with the flyer as it spiked 15.00% to $2.07, before settling in for the price of $1.80 at the close. Taking a more long-term approach, CLYM posted a 52-week range of $1.73-$11.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -46.72%. This publicly-traded company’s shares outstanding now amounts to $67.22 million, simultaneously with a float of $51.52 million. The organization now has a market capitalization sitting at $139.15 million. At the time of writing, stock’s 50-day Moving Average stood at $3.1300, while the 200-day Moving Average is $5.6400.
Climb Bio Inc (CLYM) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Climb Bio Inc’s current insider ownership accounts for 23.36%, in contrast to 71.05% institutional ownership. According to the most recent insider trade that took place on Dec 19 ’24, this organization’s CHIEF ACCOUNTING OFFICER sold 1,235 shares at the rate of 2.02, making the entire transaction reach 2,495 in total value, affecting insider ownership by 11,329. Preceding that transaction, on Sep 20 ’24, Company’s CHIEF ACCOUNTING OFFICER sold 1,191 for 8.18, making the whole transaction’s value amount to 9,741. This particular insider is now the holder of 7,564 in total.
Climb Bio Inc (NASDAQ: CLYM) Trading Performance Indicators
Let’s observe the current performance indicators for Climb Bio Inc (CLYM). It’s Quick Ratio in the last reported quarter now stands at 57.73. The Stock has managed to achieve an average true range (ATR) of 0.25.
In the same vein, CLYM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.13, a figure that is expected to reach -0.15 in the next quarter, and analysts are predicting that it will be -1.57 at the market close of one year from today.
Technical Analysis of Climb Bio Inc (CLYM)
During the previous 9 days, stock’s Stochastic %D was recorded 25.40% While, its Average True Range was 0.2500.
Raw Stochastic average of Climb Bio Inc (CLYM) in the period of the previous 100 days is set at 4.82%, which indicates a major fall in contrast to 24.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 129.34% that was higher than 88.89% volatility it exhibited in the past 100-days period.
